• July 26, 2013

    In This Issue:





    Are YOU Ready? Physician Payment Sunshine Act Begins Aug. 1

    As part of the Affordable Care Act ("ACA") enacted in 2010, The Physician Payments Sunshine Act ("Sunshine Act") requires the collection of data regarding payments and gifts made by medical device/pharmaceutical companies to physicians and teaching hospitals. Manufacturers and group purchasing organizations (GPOs) are also required to report certain ownership interests on the part of physicians and immediate families. Such data must be publicly available on a searchable Federal database starting in September 2014.

    It is the manufacturers' responsibility (not the physicians' and hospitals') to report these payments, according to specific parameters specified by the Federal Centers for Medicare & Medicaid Services (CMS).

    SCAI is urging members to learn more about -- and to prepare for -- the requirements of the Sunshine Act as soon as possible.

    Visit the SCAI.org Physician Payment Sunshine Act Resource Page

    Back to Top

    SCAI Efforts Lead to Significant Progress on SGR Draft Legislation

    As reported last week, SCAI and its Alliance of Specialty Medicine partners continued to make significant progress in engaging the House Energy and Commerce Health Subcommittee on shaping legislation to repeal and replace Medicare's sustainable growth rate (SGR) formula.

    On Monday the Alliance submitted comments to the Committee thanking it for addressing the majority of previously outlined concerns in the latest draft. On Tuesday the draft legislation was approved by the Subcommittee.

    The full Energy and Commerce Committee is expected to approve the bill this week with few changes. Stay tuned.

    Back to Top

    Mastering FFR-IVUS Online Curriculum Launches July Module

    SCAI’s Mastering FFR-IVUS Online Curriculum has launched its new module for July, "IVUS: Lesion characterization, stent apposition and vessel sizing," presented by John McB. Hodgson, MD, FSCAI. This presentation focuses on the basic morphology and measurements by IVUS, stent sizing and expansion in straightforward cases, impact of calcium on stent expansion and the causes and effects of stent malapposition.

    As with other courses in SCAI's growing eLearning Library, the FFR/IVUS course material is a complimentary benefit available to all SCAI members. CME credit will be available for purchase after all of the modules have been released. This latest addition to the Society's menu of online educational offerings features an all-new twist: the release of a new curriculum module every month.

    Program Director Morton Kern, MD, FSCAI and Course Co-Director Allen Jeremias, MD, FSCAI have designed the course to ensure learners master the curriculum and build on competencies as they are introduced. This monthly release schedule will also allow for flexibility to continuously enhance the program while ensuring the content remains both current and comprehensive.

    Access the July Module Now!

    More Information on SCAI's Mastering FFR-IVUS Online Curriculum

    Visit the SCAI eLearning Library

    This program is supported by Volcano. The Society gratefully acknowledges this support, while taking sole responsibility for all content developed and disseminated through this effort.

    Back to Top

    CCI: New Early View Content on Peripheral Vascular Disease

    In order to get critical information to members as soon as possible, SCAI's official journal Catheterization & Cardiovascular Interventions (CCI) offers accepted manuscripts online in its Early View Section prior to inclusion of that manuscript in a print issue.

    The following Early View articles in Peripheral Vascular Disease are now available online - just log in at www.SCAI.org:

    Peripheral Vascular Disease

    Original Studies


    Outcomes of carotid stenting in patients with previous neck radiation
    Akin Cam, Mehdi H. Shishehbor, Navkaranbir S. Bajaj, Alper Ozkan, Christopher T. Bajzer and Samir R. Kapadia
    ABSTRACT | Members CLICK HERE to Access Full Issue


    An evidence-based review of the impact of periprocedural myocardial infarction in carotid revascularization
    Erik Stilp, Colleen Baird, William A. Gray, Peter A. Schneider, Charles A. Simonton, Patrick Verta and Carlos I. Mena-Hurtado
    ABSTRACT | Members CLICK HERE to Access Full Issue


    Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model
    Saami K. Yazdani, Erica Pacheco, Masataka Nakano, Fumiyuki Otsuka, Scott Naisbitt, Frank D. Kolodgie, Elena Ladich, Serge Rousselle and Renu Virmani
    ABSTRACT | Members CLICK HERE to Access Full Issue


    Carotid artery stenting according to the "tailored CAS" algorithm performed in the very elderly patients: The thirty day outcome
    Karolina Dzierwa, Piotr Pieniazek, Lukasz Tekieli, Piotr Musialek, Tadeusz Przewlocki, Anna Kablak-Ziembicka, Renata Kosobucka-Peszat, Roman Machnik, Mariusz Trystula and Piotr Podolec
    ABSTRACT | Members CLICK HERE to Access Full Issue


    Learning curve for intracranial angioplasty and stenting in single center
    Qiankun Cai, Yongkun Li, Gelin Xu, Wen Sun, Yunyun Xiong, Wenshan Sun, Yuanfei Bao, Xianjun Huang, Yao Zhang, Lulu Zhou, Wusheng Zhu and Xinfeng Liu
    ABSTRACT | Members CLICK HERE to Access Full Issue


    Angiographic characteristics of femoropopliteal in-stent restenosis: Association with long-term outcomes after endovascular intervention
    Ehrin J. Armstrong, Satinder Singh, Gagan D. Singh, Khung-Keong Yeo, Shaan Ludder, Gregory Westin, David Anderson, David L. Dawson, William C. Pevec and John R. Laird
    ABSTRACT | Members CLICK HERE to Access Full Issue

    Clinical Decision Making


    An evidence-based review of the impact of periprocedural myocardial infarction in carotid revascularization
    Erik Stilp, Colleen Baird, William A. Gray, Peter A. Schneider, Charles A. Simonton, Patrick Verta and Carlos I. Mena-Hurtado
    ABSTRACT | Members CLICK HERE to Access Full Issue

    Case Report


    Acute limb ischemia due to abdominal compartment syndrome
    Atsuo Maeda, Kohei Wakabayashi and Hiroshi Suzuki
    ABSTRACT | Members CLICK HERE to Access Full Issue


    Exercise right heart catheterization for inferior vena cava obstruction: Confirming the hemodynamic significance of an anatomic lesion
    Mackram F. Eleid, Haraldur Bjarnason, Robert L. Frye and Rick A. Nishimura
    ABSTRACT | Members CLICK HERE to Access Full Issue

    Back to Top

    ELM Fellows Byline Articles in Diagnostic and Interventional Cardiology

    Two SCAI-ELM Fellows– Anita Asgar, MD, and Dmitriy N. Feldman, MD, FSCAI – recently published articles in the popular trade publication Diagnostic and Interventional Cardiology (DAIC). Drs. Asgar and Feldman responded to SCAI’s request for original articles highlighting SCAI 2013 news.

    Dr. Asgar wrote about “Challenges to the FDA Device Approval Process,” focusing on the keynote presentations by SCAI Past President and Hildner Lecturer Jeffrey J. Popma, MD, FSCAI, and FDA Center for Devices and Radiological Health entrepreneur in residence and Abbott Vascular past president Robert “Chip” Hance. Dr. Asgar’s article also reflects on the discussion during the SCAI 2013 Town Hall session, with its take-away messages on collaboration with both the FDA and the medical device industry and the need for leadership on efforts to improve clinical trials. Dr. Asgar is director of the transcatheter valve program at the Montreal Heart Institute.

    Dr. Feldman reported from “Hottest Topics 2013,” a popular session at the SCAI Scientific Sessions. His article focuses on clinical insights from five key studies:  SYNTAX (Five Year Follow Up), FREEDOM, FAME II, FIRST, and ARCTIC. Reporting on discussion during the session, which was moderated by Peter Block, MD, FSCAI, and Roxana Mehran, MD, FSCAI, Dr. Feldman’s article addresses the best treatment strategies for patients with complex multivessel disease, the utility of fractional flow reserve and intravascular ultrasound when deciding which lesions should be treated, and use of platelet function testing to tailor antiplatelet therapy for patients undergoing percutaneous coronary intervention (PCI). Dr. Feldman is director of endovascular services and assistant professor of medicine, interventional cardiology and endovascular laboratory, Weill Cornell Medical College/The New York Presbyterian Hospital, New York.

    “ELM Fellows are being prepared to be leaders in interventional cardiology, and a big part of that is showing that they can contribute actively to the Society and partnering organizations as well as advocate for the field as a whole," said Srihari S. Naidu, MD, FSCAI, SCAI ELM program chair and SCAI Trustee. "It is great to see the ELM Fellows rising to this challenge in multiple ways, including writing opportunities such as this."

    Back to Top